References
Алекян, Б.Г. Отдаленные результаты после имплантации стентов "Cypher" у 1700 пациентов - опыт НЦССХ им. А.Н. Бакулева РАМН / Б.Г. Алекян // Матер. IX Моск. межд. курса по рентгеноэндоваскулярной хирургии врожд. и приобр. пороков сердца, коронарной и сосудистой патологии. - М., 2007. - С. 167.
Беленков, Ю.Н. Инвазивная кардиология - фокус на рестеноз. Часть II / Ю.Н. Беленков, Т.А. Батыралиев, И.В. Першуков, А.Н. Самко // Кардиология. - 2002. - Т. 42, № 11. -С. 68-72.
Беленков, Ю.Н. Эпидемиологические исследования сердечной недостаточности: состояние вопроса / Ю.Н. Беленков, В.Ю. Мареев, Ф.Т. Агеев // Серд. недостат. - 2002. - № 2. - С. 57-58.
Бокерия, Л.А. Стенты с антипролиферативным лекарственным покрытием / Л.А. Бокерия, Б.Г. Алекян, А.В. Стаферов // Руководство по рентгеноэндоваскулярной хирургии сердца и сосудов; под ред. Л.А. Бокерия, Б.Г. Алекяна. - В 3-х т. - М., 2008. - Т. 3. - С. 232-260.
Ганюков, В.И. Коронарное шунтирование: рекомендации Американской аассоциации сердца и Американского кардиологического колледжа / В.И. Ганюков, Ю.Б. Юрченко, А.В. Протопопов и др.; издание информационно-методического комитета АСС/АНА. - Красноярск, 2000. - 200 с.
Ako, J. Late incomplete stent apposition following sirolimus eluting stent: serial quantitative intravascular ultrasound analysis from the SIRIUS trial / J. Ako, Y. Morino, Y. Honda et al. // J. Amer. Coll. Cardiol. - 2003. - Vol. 41. - P. 33A (Suppl. A).
Haulers, C. Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis / C. Bauters, J. Lablanshe, E. MacFadden // Ibid. - 1992. - Vol. 20. - P. 845-848.
Camenzind, E. Westside College of Cardiology, Cardiointerventional Radiology Society of the Europe 2006 / E. Camenzind et al. // WCC. - 2006. - P. 184-186 (Abstracts).
Eisenstein, E.L. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation / E.L. Eisenstein, K.J. Anstrom, D.F. Kong et al. //JAMA. - 2006. - Dec. 5. - P. E1-E10.
FDA Public Health Web Notification: Information for Physicians on Sub-acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER™ Coronary Stent. - Issued 29.10.2003.
FDA Public Health Web Notification: Information for Physicians on Sub-acute Thromboses (SAT) and Hypersensitivity Reactions with Use of the Cordis CYPHER™ Coronary Stent. - Issued 29.10.2004.
Goy, J. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world interventional cardiology: the ISAR-Diabetes trial / J. Goy, J. Stauffer, M. Siegenthaler et al. // J. Amer. Coll. Cardiol. - 2005. - Vol. 45, № 2. - P. 308-311.
Grube, E. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions / E. Grube, S. Silber, K. Hauptmann, et al. // Circulation. - 2003. - Vol. 107. - P. 38-42.
Holmes, D.R. One-year follow-up of the SIRIUS study: a randomized study with the sirolimus-eluting Bx-VELOCITY in the treatment of patients with de-novo native coronary artery lesions / D.R. Holmes, М.В. Leon, J.W. Moses et al. // J. Amer. Coll. Cardiol. - 2003. - Vol. 41. - P. 32A (Suppl. A).
Kaiser, C. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET) / C. Kaiser, H.P. Brunner-La Rocca, P.Т. Buser et al. // Lancet. - 2005. - Vol. 366. - P. 921-929.
Karvouni, E. 17 mo after SES implantation - despite ASA continuation (clopidogrel sloped at 2 mo) / E. Karvouni // Heart. - 2005. - Vol. 8. - P. 64-71.
Kastrati, A. Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents / A. Kastrati, Jul inda Mehilli, J. Pache, C. Kaiser et al. // N. Engl. J. Med. - 2007. - Vol. 356. - P. 1030-1039.
Kastrati, A. Prognostic value of the modified American College of Cardiology / American Heart Association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement / A. Kastrati, A. Schomig, S. Elezi et al. // Circulation. - 1999. - Vol. 100. - P. 1285.
Kastrati, A. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials / A. Kastrati, A. Dibra, S. Eberle et al. // JAMA. - 2005. - Vol. 294, № 7. - P. 819-825.
Leon, M.B. The effects of sirolimus-eluting stents on in-stent "and peri-stent restenosis: an angiographic subanalysis from the SIRIUS trial / M.B. Leon, J.J. Popma, S. Yakubov et al. // J. Amer. Coll. Cardiol. - 2003. - Vol. 41. - P. 14A (Suppl. A).
Morice, M. A randomized comparison of a sirolimus-eluting stent with a standart stent for coronary revascularization / M. Morice, P. Serruys, J. Souea et al. // N. Engl. J. Med. - 2002. - Vol. 346.-P. 1773-1780.
Morice, M. The RAVEL study: a randomized study with the sirolimus-coated Bx-velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions / M. Morice, P. Serruys, J. Sousa et al. // Eur. Heart J. - 2001. - Abstract.
Morris, M. Sirolimus vs Paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial / M. Morris, A. Colombo, B. Meier et al. // JAMA. - 2006. - Vol. 295, № 8. - P. 895-904.
Nordmann, A.J. Westside College of Cardiology, Cardiointerventional Radiology Society of the Europe 2006 / A.J. Nordmann // WCC. - 2006. - P. 113-118 (Abstracts).
Serruys, P.W. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease: BENESTENT study group / P.W. Serruys, P. de Jaegere, F. Kiemeneij et al. // N. Engl. J. Med. - 1994.-Vol. 331.-P. 489-509.
Sondhi, M. A Meta-Analysis Of Randomized Controlled Trials With Coronary Drug-Eluting Stents Compared With Bare-Metal Stents / M. Sondhi, A. Jagannath, J.B. Wong et al. // J. Cardiol. - 2006. - Vol. 3, № 2. - P. 343-356.
Sousa, J.E. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up / J.E. Sousa, M.A. Costa, A.C. Abizaid et al. // Circulation. - 2001. - Vol. 104. - P. 2007-2011.
Stabile, E. Marked malposition and aneurysm formation after sirolimus-eluting coronary stent implantation / E. Stabile, E. Escolar, G. Weigold et al. // Circulation. - 2004. - Vol. 110, № 5. - P. 47-48.
Stone, G. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial / G. Stone, S. Ellis, D. Cox et al. // Ibid. - 2004. - Vol. 109, № 16.-P. 1942-1947.
Stone, G.W. 15 cases - stent underexpansion is an independent predictor / G.W. Stone, M. Leon // J. Amer. Coll. Cardiol. - 2005. - Vol. 28. - P. 229-284.
US FDA Public Health Web Notification: FDA Approves Drug-Eluting Stent for Clogged Heart Arteries. - Issued 29.10.2005.
Vik-Mo, H. Coronary aneurysm after implantation of a paclitaxel-eluting stent / H. Vik-Mo, R. Wiseth, K. Hegbom // Scand. Cardiovasc. J. - 2004. - Vol. 38, № 6. - P. 349-352.
Waksman, R. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gammaradiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrei (WRIST PLUS) / R. Waksman, A.E. Ajani, R.L. White et al. // Circulation. - 2001. - Vol. 103. - P. 2332-2335.
Windecker, S. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization / S. Windecker, A. Remondino, F. Eberli et al. // N. Engl. J. Med. - 2005. - Vol. 353, № 7. - P. 653-662.
Wood, S. Day 1: FDA panel accepts stent thrombosis but rejects increased death / MI risk for on-label DES use / S. Wood // N. Engl. J. Med. - 2006. - Vol. 216.-P. 87-93.
